Home Chronic Diseases Tags

View the Latest: Chronic Diseases

Filter

List Grid

21 - 30 of 61 Results

  • Medigap May Be Elusive for Medicare Beneficiaries with Pre-Existing Conditions

    Issue Brief

    This issue brief analyzes federal and state guaranteed issue rules and how they impact beneficiaries’ access to Medigap, including the implications for Medicare beneficiaries with pre-existing conditions and those under age 65 with long-term disabilities. This brief also explores a recently finalized rule: Nondiscrimination in Health Programs and Activities regarding Section 1557 of the Affordable Care Act that may have implications for the Medigap market.

  • Views and Experiences of Puerto Ricans One Year After Hurricane Maria

    Report

    This partnership survey from The Washington Post and the Kaiser Family Foundation explores how Puerto Ricans are faring one year after Hurricane Maria struck the U.S. territory. This face-to-face survey of those living in Puerto Rico examines the impact the hurricane had on their lives, including their housing situation, financial status, and mental and physical health. It also covers issues of access to water and electricity and Puerto Ricans' views of the government’s response to the storm and its recovery. This is the first, and only, comprehensive, island-wide representative survey to assess a broad array of impacts from Hurricane Maria and hear directly from the people of Puerto Rico about what they experienced and what the ongoing needs are.

  • The $174 Billion Question: How to Reduce Diabetes and Obesity

    Event Date:
    Event

    Diabetes and obesity have evolved from a national public health concern to a problem of epidemic proportions — a very costly problem. The direct medical costs and the indirect costs of diabetes are estimated at $174 billion yearly.

  • Data Note: Medicaid’s Role in Providing Access to Preventive Care for Adults

    Issue Brief

    Chronic illness is prevalent in the adult Medicaid population. Preventive care, including immunizations and regular screenings that permit early detection and treatment of chronic conditions, improves the prospects for better health outcomes. This Data Note focuses on Medicaid’s role in providing access to preventive care for low-income adults.

  • FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries

    Issue Brief

    The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen's new FDA-approved Alzheimer's drug, which will cost $56,000 per year.